These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 24899472)

  • 21. First trimester screening for trisomy 21 in gestational week 8-10 by ADAM12-S as a maternal serum marker.
    Tørring N; Ball S; Wright D; Sarkissian G; Guitton M; Darbouret B
    Reprod Biol Endocrinol; 2010 Oct; 8():129. PubMed ID: 21034452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. First trimester maternal serum PAPP-A, beta-hCG and ADAM12 in prediction of small-for-gestational-age fetuses.
    Pihl K; Larsen T; Krebs L; Christiansen M
    Prenat Diagn; 2008 Dec; 28(12):1131-5. PubMed ID: 19003798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening models using multiple markers for early detection of late-onset preeclampsia in low-risk pregnancy.
    Park HJ; Kim SH; Jung YW; Shim SS; Kim JY; Cho YK; Farina A; Zanello M; Lee KJ; Cha DH
    BMC Pregnancy Childbirth; 2014 Jan; 14():35. PubMed ID: 24444293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maternal serum ADAM12 levels correlate with PAPP-A levels during the first trimester.
    Valinen Y; Peuhkurinen S; Järvelä IY; Laitinen P; Ryynanen M
    Gynecol Obstet Invest; 2010; 70(1):60-3. PubMed ID: 20197665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Second- and third-trimester serum levels of placental proteins in preeclampsia and small-for-gestational age pregnancies.
    Bersinger NA; Ødegård RA
    Acta Obstet Gynecol Scand; 2004 Jan; 83(1):37-45. PubMed ID: 14678084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. First-trimester screening for preeclampsia: impact of maternal parity on modeling and screening effectiveness.
    Moon M; Odibo A
    J Matern Fetal Neonatal Med; 2015; 28(17):2028-33. PubMed ID: 25330843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sequential plasma angiogenic factors levels in women with suspected preeclampsia.
    Baltajian K; Bajracharya S; Salahuddin S; Berg AH; Geahchan C; Wenger JB; Thadhani R; Karumanchi SA; Rana S
    Am J Obstet Gynecol; 2016 Jul; 215(1):89.e1-89.e10. PubMed ID: 26827880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ADAM12s and PP13 as first trimester screening markers for adverse pregnancy outcome.
    Deurloo KL; Linskens IH; Heymans MW; Heijboer AC; Blankenstein MA; van Vugt JM
    Clin Chem Lab Med; 2013 Jun; 51(6):1279-84. PubMed ID: 23241612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictive value of sFlt-1, PlGF, sFlt-1/PlGF ratio and PAPP-A for late-onset preeclampsia and IUGR between 32 and 37 weeks of pregnancy.
    Birdir C; Droste L; Fox L; Frank M; Fryze J; Enekwe A; Köninger A; Kimmig R; Schmidt B; Gellhaus A
    Pregnancy Hypertens; 2018 Apr; 12():124-128. PubMed ID: 29674192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Total and Fetal Circulating Cell-Free DNA, Angiogenic, and Antiangiogenic Factors in Preeclampsia and HELLP Syndrome.
    Muñoz-Hernández R; Medrano-Campillo P; Miranda ML; Macher HC; Praena-Fernández JM; Vallejo-Vaz AJ; Dominguez-Simeon MJ; Moreno-Luna R; Stiefel P
    Am J Hypertens; 2017 Jul; 30(7):673-682. PubMed ID: 28338787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maternal serum ADAM12 in Chinese women undergoing screening for aneuploidy in the first trimester.
    Liao C; Han J; Sahota D; Li DZ; Sun Q; Lin L; Zhou JY; Yang X; Pan M; Huang YN
    J Matern Fetal Neonatal Med; 2010 Nov; 23(11):1305-9. PubMed ID: 20230315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Second trimester maternal serum ADAM12 levels in Down's syndrome pregnancies.
    Donalson K; Turner S; Wastell H; Cuckle H
    Prenat Diagn; 2008 Oct; 28(10):904-7. PubMed ID: 18785180
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrated proteomics pipeline yields novel biomarkers for predicting preeclampsia.
    Myers JE; Tuytten R; Thomas G; Laroy W; Kas K; Vanpoucke G; Roberts CT; Kenny LC; Simpson NA; Baker PN; North RA
    Hypertension; 2013 Jun; 61(6):1281-8. PubMed ID: 23547239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Second trimester screening for trisomy 21 using ADAM12-S as a maternal serum marker].
    Jiang T; Lv L; Yang B; Sun YJ; Zhang XJ; Sun Y; Xu QJ; Xu ZF
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Jun; 29(3):314-8. PubMed ID: 22678798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictive performance of the competing risk model in screening for preeclampsia.
    Wright D; Tan MY; O'Gorman N; Poon LC; Syngelaki A; Wright A; Nicolaides KH
    Am J Obstet Gynecol; 2019 Feb; 220(2):199.e1-199.e13. PubMed ID: 30447210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Correlation of a disintegrin and metalloprotease 12 level in maternal serum during the first trimester with pregnancy outcome].
    Qi H; Bian XM; Jiang YL; Liu SY; Guo Q
    Zhonghua Fu Chan Ke Za Zhi; 2009 Jun; 44(6):401-4. PubMed ID: 19953936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation.
    O'Gorman N; Wright D; Syngelaki A; Akolekar R; Wright A; Poon LC; Nicolaides KH
    Am J Obstet Gynecol; 2016 Jan; 214(1):103.e1-103.e12. PubMed ID: 26297382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preeclampsia: increased expression of soluble ADAM 12.
    Gack S; Marmé A; Marmé F; Wrobel G; Vonderstrass B; Bastert G; Lichter P; Angel P; Schorpp-Kistner M
    J Mol Med (Berl); 2005 Nov; 83(11):887-96. PubMed ID: 16247621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiogenic markers and their longitudinal change for predicting adverse outcomes in pregnant women with chronic hypertension.
    Binder J; Kalafat E; Palmrich P; Pateisky P; Khalil A
    Am J Obstet Gynecol; 2021 Sep; 225(3):305.e1-305.e14. PubMed ID: 33812812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A disintegrin and metalloproteinase 12 (ADAM12) is reduced at 36 weeks' gestation in pregnancies destined to deliver small for gestational age infants.
    Andres F; Wong GP; Walker SP; MacDonald TM; Keenan E; Cannon P; Nguyen TV; Hannan NJ; Tong S; Kaitu'u-Lino TJ
    Placenta; 2022 Jan; 117():1-4. PubMed ID: 34768162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.